Sources | Names Used |
---|---|
CTRPv2 | BRD-K27188169:navitoclax (2:1 mol/mol) |
PharmacoGx | BRD-K27188169:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZSCAN5A | CTRPv2 | pan-cancer | AAC | 0.15 | 0.005 |
mRNA | ZSCAN30 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.003 |
mRNA | ZSCAN26 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0007 |
mRNA | ZSCAN23 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
mRNA | ZSCAN2 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0002 |
mRNA | ZSCAN18 | CTRPv2 | pan-cancer | AAC | 0.24 | 7e-06 |
mRNA | ZSCAN1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
mRNA | ZNF93 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.009 |
mRNA | ZNF91 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0004 |
mRNA | ZNF878 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.001 |